This move is archived. Current quotes and coverage live on the stock page.
Get MBX alerts:
Microbix Biosystems Inc. (MBX.TO) has seen a remarkable surge in its stock price, climbing 6.67% in just one trading day.
In the latest trading session, Microbix closed at CA$0.32, reflecting growing investor confidence in the company’s potential, even in a challenging market environment.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$42.46M
52W high
$0.33
52W low
$0.21
1W change
+5.08%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX · as of Sep 17, 2026
Wall Street analysts forecast MBX stock price to rise 29.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+29.0% Upside
Current Price
C$0.31
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
58.9%
Annualized
90-Day Vol
54.2%
Annualized
Trend (90d)
+13.8%
Annualized drift
90d Mean
C$0.33
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.32 | C$0.26 – C$0.39 |
| 60 trading days | C$0.32 | C$0.24 – C$0.43 |
| 90 trading days | C$0.33 | C$0.23 – C$0.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: As Microbix continues to innovate in the diagnostics sector, this uptick in stock price could signal positive momentum for future growth, making it a stock to watch.
Microbix Biosystems Inc. Surges 6.67% in One Day
With a market cap of CA$42.6 million, Microbix's recent performance highlights its growth potential, but investors should keep an eye on the company’s financial health.
Bull case
The recent rise in Microbix's stock price may be due to increased investor interest following its Q1 2026 revenue report, which showed a 13% revenue increase compared to the previous quarter. This positive trend suggests that the company is gaining traction in its market.
Bear case
Despite the encouraging movement, investors should stay cautious. Microbix still faces a net loss and operates in a highly competitive diagnostics market, which could impact its future performance.
Advertisement
Recent Performance and Market Reaction
Microbix's stock performance has caught attention, with a notable 6.67% increase in the last trading session. Investors are likely reacting to the company’s recent Q1 2026 revenue report, which indicated a positive trend despite ongoing financial challenges.
Looking Ahead: What Investors Should Consider
While the surge in stock price is promising, potential investors should consider Microbix's overall financial health, including its current net loss. The diagnostics industry is competitive, and continued innovation will be crucial for sustaining growth. For more insights, check out our detailed analysis of Microbix's stock performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
